Prone Positioning Short-term Effects on Tissue Oxygen Saturation in Critical COVID-19 Patients
NCT ID: NCT04692129
Last Updated: 2022-07-28
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
100 participants
OBSERVATIONAL
2020-05-29
2022-10-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Effects of Cardiovascular and Pulmonary Optimization on Cerebral Oxygenation in COVID-19 Patients With Severe ARDS
NCT04392089
Cerebral Oximetry in Lower Body Negative Pressure
NCT03009305
Depth of Sedation and Its Impact on Cerebrovascular Reactivity in Acute Respiratory Distress Syndrome: a Pilot Analysis
NCT05847634
Study of the: Effect of Head Rotation in Prone Position on Regional Cerebral Oxygen Saturation.
NCT01760369
Feasibility of End-tidal Oxygen Concentration Monitoring During Preoxygenation for Intubation in the Intensive Care Unit.
NCT05409573
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Tissue oxygenation measurements will be performed in supine position, immediately before changing to prone positioning, and repeated after 20 minutes of stabilization, once in prone position.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
* Raynaud's syndrome
* Skin lesions/trauma in upper limbs interfering the placement of the NIRS probe and/or the occlusion tourniquet
* Deep venous thrombosis in the upper limbs
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Institut de Ciències Fotòniques (ICFO)
UNKNOWN
Centre de Recerca Matemàtica
UNKNOWN
Institute of Physics University of Campinas
UNKNOWN
Corporacion Parc Tauli
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Jaume Mesquida
Principal Investigator
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Jaume Mesquida
Role: PRINCIPAL_INVESTIGATOR
Parc Taulí Hospital Universitari
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Hospital de Clñinicas da UNICAMP
Campinas, São Paulo, Brazil
Hospital General de México
México, , Mexico
Parc Taulí Hospital Universitari
Sabadell, Barcelona, Spain
Hospital Clínic i Provincial de Barcelona
Barcelona, , Spain
Hospital Parc Salut Mar
Barcelona, , Spain
Hospital Vall d'Hebron
Barcelona, , Spain
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
2020/591
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.